Skip to content

A study for performance verification of the scale for monitoring of diabetic complications

Pilot study for performance verification of the scale for monitoring of diabetic complications

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006093
Enrollment
50
Registered
2021-04-23
Start date
2022-06-21
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Subject inclusion criteria (patients with diabetes) • Diabetes: Patients with type 2 diabetes aged 40 to 85 years who visited Korea University Ansan Hospital • Criteria for neuropathy: Those who fall under any of the following criteria - Those who have been diagnosed with diabetic neuropathy - Those who are taking medications for diabetic neuropathy - Those who had findings of diabetic neuropathy on the nerve conduction test conducted at the hospital • Criteria for peripheral vascular disease: Those who fall under any of the following criteria - Those who have been diagnosed with peripheral vascular disease - Those whose results of ankle-brachial index testing conducted at the hospital are less than 1.0 - Those who are taking medications for peripheral vascular disease or have had a procedure or surgery for peripheral vascular disease ? Subject inclusion criteria (non-diabetic patients) • Adults aged 40 to 85 years who do not have diabetes and do not fall under the criteria for neuropathy or peripheral vascular disease above • Exclusion criteria are the same as those for patients with diabetics

Exclusion criteria

Exclusion criteria: • Type 1 diabetes • Those with lower extremity deformity or a history of lower extremity amputation • Lower extremity fractures or lower extremity surgery within last 3 months • Excessive sweating of the feet • Those who are determined to be not eligible for this study (Pregnant women, severe systemic diseases, mental illness, etc.)

Design outcomes

Primary

MeasureTime frame
Difference in foot heat distribution analyzed by “the scale for monitoring of diabetic complications” between Group 1 and Group 2, 3, and 4

Secondary

MeasureTime frame
Difference in foot pressure distribution analyzed by “the scale for monitoring of diabetic complications” between Group 1 and Group 2, 3, and 4;Difference in foot heat and pressure distributions analyzed by “the scale for monitoring of diabetic complications” between Group 0 and Group 1;Comparison of foot heat distributions measured by “the scale for monitoring of diabetic complications” and a non-contact infrared thermometer

Countries

Korea, Republic of

Contacts

Public ContactDa Young Lee

Korea University Ansan Hospital

ddkristin412@gmail.com+82-31-412-4822

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026